Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity

被引:24
作者
Castagnola, Elio [1 ]
Tatarelli, Paola [2 ]
Mesini, Alessio [2 ]
Baldelli, Ivana [2 ]
La Masa, Daniela [1 ]
Biassoni, Roberto [1 ]
Bandettini, Roberto [1 ]
机构
[1] Childrens Hosp, IRCCS Ist Giannina Gaslini, Genoa, Italy
[2] Univ Genova DISSAL, Infect Dis Div, Genoa, Italy
关键词
Carbapenemase; Enterobacteriaceae; Pediatrics; RESISTANT KLEBSIELLA-PNEUMONIAE; INTENSIVE-CARE-UNIT; RISK-FACTORS; INFECTIONS; COLONIZATION; CHILDREN; SPREAD; OUTBREAK;
D O I
10.1016/j.jiph.2018.11.003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Little is known about epidemiology of carbapenemase-producing Enterobacteriaceae (CPE) in children. Aim of this study was to describe CPE epidemiology in a tertiary care pediatric hospital in Italy that admits patients coming from geographic areas with high diffusion of CPE. Methods: Prospective evaluation of the proportion and rates per 100,000 hospital discharges (D) or hospitalization-days (HD) of invasive infections due to CPE from 2013 to 2017 and of CPE infections and colonizations from 2014 to 2017. Disease-preventing strategies comprised patients' screening at admission, pre-emptive contact isolation precautions pending cultures results, and bundles for prevention of healthcare associated infections. Results: From 2013 to 2017 CPE represented 3.5% of all invasive infections due to Enterobacteriaceae, with rates ranging 7.30-14.33 for D and 1.03-2.06 for HD, without major changes over time. On the contrary, overall rates of isolates increased from 83.03 to 191.34 for D and from 12.21 to 28.35 for HD. The intra-hospital diffusion consisted of 2 small outbreaks without invasive diseases in 2014-2015, and sporadic, not epidemiologically-related cases in 2016-2017. Globally, Escherichia coli and Klebsiella pneumoniae represented 64% of identified CPE, while 70% of carbapenemases identified were metallo-beta-lactamases (VIM or NDM), with changes over time. Conclusions: In our center metallo-beta lactamases were the most frequently identified carbapenemases in Enterobacteriaceae and E. coli and K. pneumoniae the most frequently isolated pathogens carrying these enzymes. A proactive management strategy was effective in containing in-hospital spreading. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:270 / 274
页数:5
相关论文
共 43 条
  • [1] Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015
    Albiger, B.
    Glasner, C.
    Struelens, M. J.
    Grundmann, H.
    Monnet, D. L.
    [J]. EUROSURVEILLANCE, 2015, 20 (45): : 17 - 34
  • [2] [Anonymous], [No title captured]
  • [3] [Anonymous], 2013, EUCAST GUID DET RES
  • [4] Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France
    Birgand, Gabriel
    Leroy, Christophe
    Nerome, Simone
    Liem Binh Luong Nguyen
    Lolom, Isabelle
    Armand-Lefevre, Laurence
    Ciotti, Celine
    Lecorre, Bertrand
    Marcade, Geraldine
    Fihman, Vincent
    Nicolas-Chanoine, Marie-Helene
    Pelat, Camille
    Perozziello, Anne
    Fantin, Bruno
    Yazdanpanah, Yazdan
    Ricard, Jean-Damien
    Lucet, Jean-Christophe
    [J]. BMJ OPEN, 2016, 6 (01):
  • [5] Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae
    Borer, Abraham
    Saidel-Odes, Lisa
    Eskira, Seada
    Nativ, Ronit
    Riesenberg, Klaris
    Livshiz-Riven, Ilana
    Schlaeffer, Francisc
    Sherf, Michael
    Peled, Nejama
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2012, 40 (05) : 421 - 425
  • [7] Novel VIM Metallo-β-Lactamase Variant, VIM-24, from a Klebsiella pneumoniae Isolate from Colombia
    Camila Montealegre, Maria
    Correa, Adriana
    Briceno, David F.
    Rosas, Natalia C.
    De La Cadena, Elsa
    Ruiz, Sory J.
    Mojica, Maria F.
    Dario Camargo, Ruben
    Zuluaga, Ivan
    Marin, Adriana
    Quinn, John P.
    Virginia Villegas, Maria
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 2428 - 2430
  • [8] Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
    Canton, R.
    Akova, M.
    Carmeli, Y.
    Giske, C. G.
    Glupczynski, Y.
    Gniadkowski, M.
    Livermore, D. M.
    Miriagou, V.
    Naas, T.
    Rossolini, G. M.
    Samuelsen, O.
    Seifert, H.
    Woodford, N.
    Nordmann, P.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (05) : 413 - 431
  • [9] Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy
    Caselli, Desiree
    Cesaro, Simone
    Fagioli, Franca
    Carraro, Francesca
    Ziino, Ottavio
    Zanazzo, Giulio
    Meazza, Cristina
    Colombini, Antonella
    Castagnola, Elio
    [J]. INFECTIOUS DISEASES, 2016, 48 (02) : 152 - 155
  • [10] Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children
    Chiotos, Kathleen
    Tamma, Pranita D.
    Flett, Kelly B.
    Naumann, Matthew
    Karandikar, Manjiree V.
    Bilker, Warren B.
    Zaoutis, Theoklis
    Han, Jennifer H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)